PepGen Inc. (PEPG)
NASDAQ: PEPG · Real-Time Price · USD
5.22
0.00 (0.00%)
At close: Jan 29, 2026, 4:00 PM EST
5.31
+0.09 (1.70%)
After-hours: Jan 29, 2026, 4:44 PM EST
PepGen Employees
PepGen had 57 employees as of September 30, 2025. The number of employees decreased by 19 or -25.00% compared to the same quarter last year.
Employees
57
Change
-19
Growth
-25.00%
Revenue / Employee
n/a
Profits / Employee
-$1,641,351
Market Cap
358.87M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 57 | -19 | -25.00% |
| Jun 30, 2025 | 62 | -10 | -13.89% |
| Mar 31, 2025 | 79 | 14 | 21.54% |
| Dec 31, 2024 | 81 | 17 | 26.56% |
| Sep 30, 2024 | 76 | 13 | 20.63% |
| Jun 30, 2024 | 72 | 18 | 33.33% |
| Mar 31, 2024 | 65 | 16 | 32.65% |
| Dec 31, 2023 | 64 | 19 | 42.22% |
| Sep 30, 2023 | 63 | 23 | 57.50% |
| Jun 30, 2023 | 54 | 18 | 50.00% |
| Mar 31, 2023 | 49 | 18 | 58.06% |
| Dec 31, 2022 | 45 | 14 | 45.16% |
| Sep 30, 2022 | 40 | 17 | 73.91% |
| Jun 30, 2022 | 36 | 24 | 200.00% |
| Mar 31, 2022 | 31 | 19 | 158.33% |
| Dec 31, 2021 | 31 | - | - |
| Sep 30, 2021 | 23 | - | - |
| Jun 30, 2021 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 650 |
| Rocket Pharmaceuticals | 299 |
| Entrada Therapeutics | 183 |
| Enanta Pharmaceuticals | 120 |
| Aura Biosciences | 109 |
| Neumora Therapeutics | 95 |
| Lineage Cell Therapeutics | 77 |
| Tectonic Therapeutic | 51 |
PEPG News
- 7 weeks ago - PepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Business and Legal Officer - Business Wire
- 7 weeks ago - PepGen Appoints Joseph Vittiglio, Esq., as Chief Business and Legal Officer - Business Wire
- 2 months ago - PepGen Announces Issuance of U.S. Patent for Proprietary PGN-EDODM1 Molecule - Business Wire
- 2 months ago - PepGen Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights - Business Wire
- 3 months ago - PepGen to Participate in Upcoming Investor Conferences - Business Wire
- 4 months ago - PepGen: DMD Discontinued, Ways To Go With DM1 - Seeking Alpha
- 4 months ago - PepGen Announces Oral Presentations at the 30th Annual International Congress of the World Muscle Society - Business Wire
- 4 months ago - PepGen Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares - Business Wire